The 340B drug pricing program was created to improve access to outpatient medications for low-income and underinsured r uninsured patients. It has exponentially grown with the expansion of the definition of a covered entity and the change to allow multiple contract pharmacies. Still, there are debates about the program’s financial impact and whether the discounts are passed along to enough underinsured or uninsured patients.
Maxik K, Kimble C, Coustasse A. Consider Real Costs Before Implementing a 340B Program. Pharmacy Times: Directions in Health-System Pharmacy; September, 2020;25-26.